◆英語タイトル:iCubate Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2747864PD
◆発行会社(調査会社):
GlobalData
◆発行日:2021年1月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
iCubate Inc (iCubate) is a molecular diagnostic company that provides molecular diagnostic and in vitro diagnostic testing devices for syndromic testing. It develops cassettes and assays. The company’s pipeline products include flu typing cassette; HAI cassette; and STD cassette. iCubate utilizes multiplex polymerase chain reaction (mPCR) technology which is an integrated platform for automated sample preparation, amplification and detection preparation. The company also developing iCubate 2.0, an open platform that develops and markets mPCR assays. Its products are widely used in the treatment of infectious diseases. iCubate is headquartered in Huntsville, Alabama, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company iCubate Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
iCubate Inc Company Overview
iCubate Inc Company Snapshot
iCubate Inc Pipeline Products and Ongoing Clinical Trials Overview
iCubate Inc – Pipeline Analysis Overview
iCubate Inc – Key Facts
iCubate Inc – Major Products and Services
iCubate Inc Pipeline Products by Development Stage
iCubate Inc Pipeline Products Overview
iC-COVID19 Assay
iC-COVID19 Assay Product Overview
iC-GN Assay – Gram-Negative Rods
iC-GN Assay – Gram-Negative Rods Product Overview
iC-GPC Assay
iC-GPC Assay Product Overview
iC-Myco Assay
iC-Myco Assay Product Overview
iCubate Inc – Key Competitors
iCubate Inc – Key Employees
iCubate Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
iCubate Inc, Recent Developments
Aug 08, 2019: iCubate presents data on the iC-Myco Assay at the American Association of Clinical Chemistry Meeting
Aug 02, 2019: iCubate earns FDA “breakthrough device” designation for latest assay
Jul 23, 2019: Huntsville’s iCubate announces FDA clearance for innovative bloodstream infection testing
Jul 12, 2019: Icubate earns FDA clearance for latest assay
Jun 27, 2019: iCubate receives CE IVD mark for bloodstream infection assay
Aug 23, 2017: iCubate Receives CE Mark for the iC-GPC Assay
Aug 22, 2017: iCubate Receives CE Mark for the iC-GPC Assay for use on the iC-System
Aug 10, 2017: iCubate Earns FDA Clearance for iC-GPC Assay A Unique Diagnostic Solution for the diagnosis of Bloodstream Infections
Aug 10, 2017: iCubate Earns FDA Clearance for iC-System for the diagnosis of Bloodstream Infections
Oct 06, 2016: iCubate forms Scientific Advisory Board
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
iCubate Inc Pipeline Products and Ongoing Clinical Trials Overview
iCubate Inc Pipeline Products by Equipment Type
iCubate Inc Pipeline Products by Indication
iCubate Inc, Key Facts
iCubate Inc, Major Products and Services
iCubate Inc Number of Pipeline Products by Development Stage
iCubate Inc Pipeline Products Summary by Development Stage
iC-COVID19 Assay - Product Status
iC-COVID19 Assay - Product Description
iC-GN Assay - Gram-Negative Rods - Product Status
iC-GN Assay - Gram-Negative Rods - Product Description
iC-GPC Assay - Product Status
iC-GPC Assay - Product Description
iC-Myco Assay - Product Status
iC-Myco Assay - Product Description
iCubate Inc, Key Employees
iCubate Inc, Joint Venture
Glossary